AOD-9604 vs GLP-3 RT GLP-3 RT (retatrutide) adds a third receptor target glucagon on top of the GIP/GLP-1 combination, representing the broadest incretin-pathway approach among compounds referenced in this comparison
Compounded products are not evaluated by the FDA for safety, efficacy, or quality
Elevated NNMT is linked to: Reduced NAD+ availability Slower mitochondrial function Increased fat storage efficiency Higher risk for insulin resistance By reducing NNMT activity, 5-Amino-1MQ allows the body to maintain higher NAD+ levels, which can support better mitochondrial performance, improved fat oxidation, and more balanced energy metabolism
GLP-1 down-regulates mRNA expression of SOCS-3 and SREBP-1c in rats with nonalcoholic fatty liver disease
ALOXs, which are nonheme iron-containing enzymes, directly introduce molecular oxygen into PUFAs and PUFA-containing lipids within biological membranes